Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences
Domenico Sergi, Justine Renaud, Nicola Simola, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Potential roles of branched-chain amino acids in neurodegeneration
Hyung-Suk Yoo, Ushananthini Shanmugalingam, Patrice D. Smith
Nutrition (2022) Vol. 103-104, pp. 111762-111762
Closed Access | Times Cited: 16
From diabetic hyperglycemia to cerebrovascular Damage: A narrative review
Richard Simon Machado, Khiany Mathias, Larissa Joaquim, et al.
Brain Research (2023) Vol. 1821, pp. 148611-148611
Closed Access | Times Cited: 9
RGS10 mitigates high glucose-induced microglial inflammation via the reactive oxidative stress pathway and enhances synuclein clearance in microglia
Jaegwon Chung, Janna Jernigan, Kelly B. Menees, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Ferroptosis—A Shared Mechanism for Parkinson’s Disease and Type 2 Diabetes
C. Duta, Corina Muscurel, Carmen Beatrice Dogaru, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8838-8838
Open Access | Times Cited: 3
The Neuroinflammatory and Neurotoxic Potential of Palmitic Acid Is Mitigated by Oleic Acid in Microglial Cells and Microglial-Neuronal Co-cultures
Jimmy Beaulieu, Giulia Costa, Justine Renaud, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 6, pp. 3000-3014
Closed Access | Times Cited: 23
Anti-Apoptotic and Anti-Inflammatory Role of Trans ε-Viniferin in a Neuron–Glia Co-Culture Cellular Model of Parkinson’s Disease
Domenico Sergi, Alex Gélinas, Jimmy Beaulieu, et al.
Foods (2021) Vol. 10, Iss. 3, pp. 586-586
Open Access | Times Cited: 20
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
Sourav De, Yung‐Chih Kuo
Journal of the Taiwan Institute of Chemical Engineers (2024) Vol. 157, pp. 105401-105401
Closed Access | Times Cited: 2
The complex interplay between oxinflammation, mitochondrial dysfunction and lipotoxicity: Focus on their role in the pathogenesis of skeletal muscle insulin resistance and modulation by dietary fatty acids
Angelina Passaro, Juana María Sanz, Nenad Naumovski, et al.
Advances in Redox Research (2024) Vol. 11, pp. 100100-100100
Open Access | Times Cited: 2
Influence of Type 2 Diabetes and Adipose Tissue Dysfunction on Breast Cancer and Potential Benefits from Nutraceuticals Inducible in Microalgae
Domenico Sergi, Mattia Melloni, Angelina Passaro, et al.
Nutrients (2024) Vol. 16, Iss. 19, pp. 3243-3243
Open Access | Times Cited: 2
The manifold roles of protein S-nitrosylation in the life of insulin
Hua‐Lin Zhou, Richard T. Premont, Jonathan S. Stamler
Nature Reviews Endocrinology (2021) Vol. 18, Iss. 2, pp. 111-128
Open Access | Times Cited: 17
Type 2 diabetes mellitus augments Parkinson’s disease risk or the other way around: Facts, challenges and future possibilities
Mohd Faizan, Alika Sarkar, Mahendra Pratap Singh
Ageing Research Reviews (2022) Vol. 81, pp. 101727-101727
Closed Access | Times Cited: 11
Deciphering Intertwined Molecular Pathways Underlying Metabolic Syndrome Leading to Parkinson’s Disease
Ritu Soni, Jigna Shah
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 15, pp. 2240-2251
Closed Access | Times Cited: 10
The Inhibition of Metabolic Inflammation by EPA Is Associated with Enhanced Mitochondrial Fusion and Insulin Signaling in Human Primary Myotubes
Domenico Sergi, Natalie D. Luscombe‐Marsh, Leonie K. Heilbronn, et al.
Journal of Nutrition (2020) Vol. 151, Iss. 4, pp. 810-819
Open Access | Times Cited: 14
β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study
Sibylle de Germay, Cécile Conte, Olivier Rascol, et al.
CNS Drugs (2020) Vol. 34, Iss. 7, pp. 763-772
Closed Access | Times Cited: 12
Association Between Metabolic Syndrome and Mild Parkinsonian Signs Progression in the Elderly
Ziyi Peng, Rui Zhou, Dong Liu, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 11
Cognitive impairments in type 1 diabetes mellitus
Yu. V. Bykov, Vladimir Baturin
Сибирский научный медицинский журнал (2023) Vol. 43, Iss. 1, pp. 4-12
Open Access | Times Cited: 4
Ameliorating Effect of S-Allyl Cysteine (Black Garlic) on 6-OHDA Mediated Neurotoxicity in SH-SY5Y Cell Line
Yeşim Yeni, Betül Çiçek, Serkan Yıldırım, et al.
Toxicology Reports (2024) Vol. 13, pp. 101762-101762
Open Access | Times Cited: 1
Long-term diabetic hyperglycaemia modifies social behaviour in rats
Justine Renaud, Alexandre Clouet, Giulia Costa, et al.
Endocrine and Metabolic Science (2024) Vol. 16, pp. 100197-100197
Open Access | Times Cited: 1
Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson’s Disease-like Pathology in Mice
Ritu Soni, Kirti Mathur, Hritik Rathod, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 4155-4164
Closed Access | Times Cited: 1
Metabolic Dysfunction in Parkinson’s Disease: Unraveling the Glucose–Lipid Connection
Jeswinder Sian‐Hülsmann, Peter Riederer, Tanja Maria Michel
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2841-2841
Open Access | Times Cited: 1
Progranulin Preserves Autophagy Flux and Mitochondrial Function in Rat Cortical Neurons Under High Glucose Stress
Cass Dedert, Vandana Mishra, Geetika Aggarwal, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 7
Lowering the risk of Parkinson’s disease with GLP-1 agonists and DPP4 inhibitors in type 2 diabetes
Ece Bayram, Irene Litvan
Brain (2020) Vol. 143, Iss. 10, pp. 2868-2871
Open Access | Times Cited: 10
Multifactoriality of Parkinson’s Disease as Explored Through Human Neural Stem Cells and Their Transplantation in Middle-Aged Parkinsonian Mice
Anna Nelke, Silvia García‐López, Alberto Martínez‐Serrano, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 6
Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
Carolin Thomas, Lia Wurzer, Ernst Malle, et al.
Frontiers in Aging (2022) Vol. 3
Open Access | Times Cited: 6
Isolated dream‐enactment behaviours as a prodromal hallmark of rapid eye movement sleep behaviour disorder
Bei Huang, Jihui Zhang, Jing Wang, et al.
Journal of Sleep Research (2022) Vol. 32, Iss. 3
Closed Access | Times Cited: 6

Scroll to top